AABIFNCOV Genetic and immunological basis of autoantibodies against type I interferons predisposing to severe forms of COVID-19.

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    -99
  • Known Financial Commitments (USD)

    $0
  • Funder

    ANR
  • Principal Investigator

    Aurélie Cobat
  • Research Location

    France
  • Lead Research Institution

    N/A
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The AABIFNCOV project concerns the study of the genetic and immunological bases of autoantibodies (auto-Ab) directed against type I interferons and predisposing to severe forms of Covid-19. He will focus on detecting the presence of these auto-antibodies with more sensitive methods, in large cohorts of patients with different grades of severity, but also in family members of individuals with auto-Ac, in the plasma of convalescent patients intended for transfusion, in subjects with only one functional X chromosome, as well as in individuals of the general population. It will also analyze by sequencing the whole genome the genetic variants, in particular linked to the X chromosome, which could explain the development of these auto-Acs, and validate them experimentally.